Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

If the rate is slower or faster than that, it can be the sign of an underlying health condition, such as heart disease, lung disease, or anxiety. Respiration rate is how many breaths a person ...

The first AI-powered companion diagnostic for non-small cell lung cancer has received FDA Breakthrough Device Designation. Developed by Roche, Ventana TROP2 RxDx Device combines IHC with a digital ...

pulmonary hypertension, and right ventricular hypertrophy. The new study in The American Journal of Pathology, published by Elsevier, details the potential for the model to unravel the complex ...

Panel A shows the cumulative number of moderate or severe exacerbations from baseline to week 104 among patients with chronic obstructive pulmonary disease who received mepolizumab (at a dose of ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

In fact, the progress in reducing overall cancer deaths is largely attributable to sustained declines in both incidence and death rates of lung cancer and several other smoking-related cancers ...

the lesion in the patient’s right lung is undetectable after two months and confirmed resolved at 4 months. The updated images supersede those previously reported. The patient, a 78-year-old ...

Researchers in Nikolaus Rajewsky’s lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to ...

Everyday Health’s team of board-certified physicians and health professionals contribute to the creation and review of content, ensuring that the information is useful, up-to-date, and accurate.

Earlier this year, Mellencamp said doctors discovered several tumors in her brain and lung, which she confirmed were metastases of melanoma and would be treated with surgery and immunotherapy.

Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of ...